Highly expressed PD-L1 in glioblastoma CSCs was recovered in the mechanism of the EMT/β-catenin/STT3/PD-L1 signalling axis [113]; however, it was still difficult to treat patients with glioblastoma, as the clinical trials are yet to reveal significant improvement in terms of outcomes [114]. The gene discussed is CD274; the disease is glioblastoma.